Fig. 2: Heat map representing the relevant canonical pathways of ASA treatments at 200, 500, and 1000 μM.

Most activated or inhibited canonical pathways as estimated by the z-score (±≥ 2) for each comparison from ingenuity Pathway analysis (IPA). Blue denotes predicted activation and orange predicted inhibition.